Composition
- Active ingredients
- SERMORELIN ACETATE EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- SERMORELIN ACETATE EQ 0.5MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableThis page
- SERMORELIN ACETATE EQ 1MG BASE/VIAL **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA020443-002 · Discontinued
- SERMORELIN ACETATE EQ 0.05MG BASE/AMP **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · InjectableNDA019863-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA020443.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Brand name
- Geref
- Active substance
- sermorelin acetate
- Route
- Injection
- Dosage form
- Injectable
- Applicant
- Emd Serono Inc
- Status
- Discontinued
- FDA approval
- 26 Sept 1997
- Application
- NDA020443-001